Tessera
Folgen

SPARK NS

@sparkns.bsky.social

SPARK NS is an independent nonprofit organization dedicated to advancing promising academic discoveries in Parkinson’s disease and autism from the lab to the clinic. Learn more: https://sparkns.org/

28 Posts27 Follower112 Folgt
SPARK NS@sparkns.bsky.social · 3w ago

Most scientific discoveries never make it to patients. Not because the science isn’t promising, but because the drug development process is complex, and rarely taught in academia. That’s why we created the SPARK NS Learning Center. Read our latest article to learn more: sparkns.org/news-and-ins...

SPARK NS Learning Center: Helping More Discoveries Reach Patients

Now all researchers interested in developing therapeutics for autism, Parkinson's, or adjacent conditions can request access to the SPARK NS Learning Center.

sparkns.org

SPARK NS@sparkns.bsky.social · 4w ago

🔔The SPARK NS Learning Center is now available to all researchers interested in or currently developing therapeutics for autism, Parkinson’s, and adjacent conditions. Researchers working in other areas can also request access. *It’s free!* Learn more and request access: na2.hubs.ly/H06n27-0

SPARK NS@sparkns.bsky.social · last mo.

How do promising therapies reach patients faster than traditional timelines allow?  Through programs such as Accelerated Approval and fast-track designations, regulatory agencies are helping to speed access to life-changing therapies while maintaining scientific rigor. sparkns.org/news-and-ins...

A Faster Future for Medicines

From accelerated approval to breakthrough therapy designation, regulators have expanded opportunities for getting promising drugs to patients faster.

sparkns.org

SPARK NS@sparkns.bsky.social · 2mo ago

Applications for the SPARK NS Translational Research Program, 2027 Cohort, are now closed! Thank you to everyone who applied! WHAT'S NEXT? Finalists will be notified in Sep with presentations in Oct. The 2027 Cohort will be selected by the end of 2025 and join the program in Jan 2027.

Bild
SPARK NS@sparkns.bsky.social · 3mo ago

Many Parkinson’s and autism discoveries are published in scientific journals. Far fewer reach patients. Why do so many promising discoveries never make it to the clinic? Read the article: sparkns.org/news-and-insights/before-the-deadline-hear-from-researchers-inside-the-spark-ns-program/

Before the Deadline, Hear from Researchers Inside the SPARK NS Program

PIs in the SPARK NS program reflect on the challenges, expertise, and support needed to move Parkinson’s and autism discoveries toward patients.

sparkns.org

SPARK NS@sparkns.bsky.social · 3mo ago

New findings from Alice Chen-Plotkin, MD, Parker Family Professor of Neurology, @upenn.edu, and a principal investigator in the SPARK NS program point to a potential new path toward slowing #ParkinsonsDisease progression. @alicechenplotkin.bsky.social www.cell.com/neuron/fullt...

Secreted GPNMB enhances uptake of fibrillar alpha-synuclein in a non-cell-autonomous process that can be blocked by anti-GPNMB antibodies

GPNMB, encoded by a Parkinson’s disease (PD) risk gene, is secreted by microglia in response to neuronal damage. Microglia-derived GPNMB can enhance uptake of pathological forms of alpha-synuclein—the...

cell.com

SPARK NS@sparkns.bsky.social · 3mo ago

The best reasons to apply to the SPARK NS program don’t come from SPARK NS. Hear below a message from Miratul Muqit, PhD, Professor of Experimental Neurology, University of Dundee, and Director of UK Dementia Research Institute Parkinson’s Research Centre, University of Edinburgh. @ukdri.ac.uk

SPARK NS@sparkns.bsky.social · 3mo ago

Every Parkinson’s researcher has a different starting point. Some started in a moment with a patient. Others were inspired in a university or medical school course. One started by watching a television show! Learn more about the SPARK NS program and how to apply: lnkd.in/gy_nsHFU #Parkinsons